PKCβII-ACSL4 pathway mediating ferroptosis execution and anti-tumor immunity

Cancer Commun (Lond). 2022 Jul;42(7):583-586. doi: 10.1002/cac2.12319. Epub 2022 Jun 8.

Authors

Guang Lei¹, Amber Horbath¹, Zhuang Li¹, Boyi Gan^{1

2}

Affiliations

¹ Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
² The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, 77030, USA.

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural

MeSH terms

Cell Line, Tumor
Ferroptosis*
Humans
Protein Kinase C beta

Substances

Protein Kinase C beta

Grants and funding